RYTM - Rhythm Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RYTM is currently covered by 13 analysts with an average price target of $142.11. This is a potential upside of $36.62 (38.73%) from yesterday's end of day stock price of $102.44.

Rhythm Pharmaceuticals's activity chart (see below) currently has 182 price targets and 180 ratings on display. The stock rating distribution of RYTM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.91% with an average time for these price targets to be met of 215.33 days.

Highest price target for RYTM is $160, Lowest price target is $105, average price target is $142.11.

Most recent stock forecast was given by LISA WALTER from RBC on 05-Aug-2026. First documented stock forecast 30-Oct-2017.

Best performing analysts who are covering RYTM - Rhythm Pharmaceuticals:

Seamus Fernandez Whitney Ijem Paul Matteis Dae Gon Ha Jonathan Wolleben

Currently out of the existing stock ratings of RYTM, 44 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2026

$155

$50.29 (48.03%)

$141

1 months 9 days ago
(05-Aug-2026)

0/5 (0%)

$44.29 (40.01%)

Buy Since 17-Mar-2026

$143

$38.29 (36.57%)

$142

1 months 9 days ago
(05-Aug-2026)

0/4 (0%)

$32.29 (29.17%)

Buy Since 17-Sep-2024

$160

$55.29 (52.80%)

$155

1 months 9 days ago
(05-Aug-2026)

6/14 (42.86%)

$49.29 (44.52%)

84

Buy Since 02-Mar-2023

$151

$41.16 (37.47%)

$140

2 months 29 days ago
(16-Jun-2026)

10/13 (76.92%)

$61.28 (68.30%)

302

Buy Since 26-Oct-2020

$155

$45.16 (41.11%)

$144

2 months 30 days ago
(15-Jun-2026)

10/16 (62.5%)

$65.3 (72.80%)

268

Show more analysts

Please expand the browser size to see the chart

What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?

On average it took 215 days for the stock forecasts to be reached, with an average price target met ratio of 72.91%.

Which analyst most recently updated their price target on RYTM (Rhythm Pharmaceuticals)?

Lisa Walter

Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?

Lisa Walter works at RBC and has 13 price targets and 7 ratings on RYTM

Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?

Corinne Jenkins with the highest potential upside of $60.21

Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?

Graig Suvannavejh with the lowest potential downside of -$78.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?